Course Viewing Requirements
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
Questions for the CME accreditor may be directed to Postgraduate Institute of Medicine at www.pimed.com.
The faculty acknowledge the editorial assistance of Global Academy for Medical Education, LLC, and Josh Kilbridge, medical writer, in the development of this activity.
This continuing medical education (CME/CE) activity was developed from faculty interviews. The opinions expressed are those of the faculty and do not necessarily reflect the views of the accredited provider, supporter, or of the publisher.
Joint Providership and Accreditation Statements
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Academy for Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Postgraduate Institute for Medicine.
After participating in this educational activity, participants should be better able to:
- Utilize the signs, symptoms, and epidemiology of IPF to better recognize patients in need of specialty care.
- Employ a multidisciplinary care team approach for IPF to enhance patient outcomes.
- Provide timely referral of patients with IPF to tertiary care to improve survival.
- Review clinical trial data supporting the efficacy and safety of pirfenidone and nintedanib.
- Select appropriate pharmacologic therapy for patients with IPF.
- Communicate with IPF patients and provide effective disease-state education.
Method of Participation
Participants should read the activity information, including the learning objectives and disclosure material. Once this information is reviewed, click the “Begin CME/CE Activity” button to enter the course. This online education is conducted within a simulation-based, technology platform using real-word clinical scenarios. You advance through the activity based on selections of distinct treatment and management choices. After you’ve ended the activity, to receive CME/CE credit, you must click the “Claim CME/CE Credits” button, and complete the online post-test and evaluation. Upon finishing and achieving a passing score on the post-test, you may request to receive your certificate of credit via email or print it out at that time.
Inquiries may be directed to Global Academy for Medical Education at firstname.lastname@example.org or (973) 290-8225.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.
Gregory P. Cosgrove, MD, FCCP—Dr. Cosgrove has been a consultant for: Boehringer Ingelheim, Genentech, and Global Blood Therapeutics. He also owns stock in Boehringer Ingelheim, Bristol Myer Squibb, and Genentech
Jonathan H. Chung, MD—Dr. Chung has no relevant financial relationships to disclose.
Christine Garcia, MD, PhD—Dr. Garcia has been a consultant for: Pliant Therapeutics, Inc and SAB Biotherapeutics, Inc
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Contact Information for Technical Questions
Please technical questions or concerns to Global Academy for Medical Education at 973-290-8225 or email email@example.com.
Copyright © 2016 by Global Academy for Medical Education, LLC and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.